Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Forecast 2026–2035: Long-Term Growth Insights
Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What level of growth is expected in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market between 2026 and 2030?
The minimally invasive glaucoma surgery (MIGS) devices market size has seen substantial growth recently. It is forecast to rise from $0.89 billion in 2025 to $1.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 28.1%. This historical growth can be attributed to the increasing prevalence of glaucoma, a growing aging population, the limitations of conventional glaucoma surgeries, rising awareness of vision preservation, and increasing adoption of cataract surgeries.
The minimally invasive glaucoma surgery (migs) devices market is projected to experience rapid expansion over the upcoming years. This market is forecast to reach a size of $2.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.9%. Factors contributing to this growth during the forecast period include an expanding patient population with glaucoma, increasing adoption of minimally invasive surgical solutions, a surge in demand for outpatient eye procedures, a greater emphasis on patient quality-of-life results, and enhanced availability of specialized ophthalmology centers. Key trends anticipated during the forecast period encompass a growing uptake of minimally invasive glaucoma procedures, an escalating preference for MIGS in cases of early and moderate glaucoma, an increased application of MIGS alongside cataract surgery, the broadening scope of outpatient and ambulatory glaucoma surgeries, and a surging need for glaucoma treatments that are both safer and offer quicker recovery.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp
Which Drivers Are Expected To Impact The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market During The Forecast Period?
The growing occurrence of eye disorders is anticipated to fuel the expansion of minimally invasive glaucoma surgery (MIGS) devices moving forward. Eye disorders comprise a wide array of conditions impacting vision and the eyes, with their prevalence increasing due to shifts in lifestyle, environmental influences, and an aging global population. Minimally invasive glaucoma surgery (MIGS) devices are innovative tools employed in treating various eye diseases, primarily focused on reducing intraocular pressure (IOP) to prevent or control the progression of glaucoma. For instance, in 2024, the National Eye Institute, a US-based government agency, projected that around 2.2 million Americans will be blind or partially blind by 2030. Therefore, the rising incidence of eye disorders acts as a key driver for the minimally invasive glaucoma surgery (MIGS) devices market.
How Is The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Divided Into Segments?
The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented –
1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices
2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures
3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space
4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals
Subsegments:
1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents
2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts
3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents
4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices
Which Competitive Trends Are Impacting The Structure Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Leading companies in the minimally invasive glaucoma surgery (MIGS) devices market are prioritizing the development of advanced solutions, such as sustained-release drug-delivery implants, aimed at replacing traditional topical glaucoma treatments. A sustained-release implant is defined as a device that delivers medication continuously over time, thereby improving patient adherence, reducing dosing frequency, and enhancing treatment efficacy. For example, in February 2024, Celanese Corporation, a US-based specialty materials company, collaborated with Glaukos to commercially introduce the iDose® TR (Travoprost Intracameral Implant), leveraging Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This innovation effectively supersedes traditional eye-drop regimens by providing continuous intraocular delivery of travoprost directly to the eye for several months. Integrated within Glaukos’ MIGS portfolio, it offers a minimally invasive therapeutic option that decreases the need for daily eye drops, improves patient compliance, and supports sustained intraocular pressure control, ultimately enhancing long-term treatment outcomes.
Which Major Industry Participants Are Leading The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth?
Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International
Access The Complete Report For Deeper Market Insights:
Which Geographic Areas Are Emerging As Strong Markets For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp
Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2026, By The Business Research Company
Glaucoma Surgery Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report
Cataract Surgery Devices And Equipment Global Market Report 2026
Ophthalmic Handheld Surgical Instruments Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
